Volume 27, Issue 1 (3-2024)
J Arak Uni Med Sci 2024, 27(1): 46-52 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hekmatpou P, Maryam Ghanbari M, Gholami M. Association Study of rs1421085 and rs9939609 in FTO Gene with Gestational Diabetes in the Arak City. J Arak Uni Med Sci 2024; 27 (1) :46-52
URL: http://jams.arakmu.ac.ir/article-1-7649-en.html
URL: http://jams.arakmu.ac.ir/article-1-7649-en.html
1- Department of Genetics, Faculty of Biological Sciences, Tehran North Branch, Islamic Azad University, Tehran, Iran
2- Department of Microbial Biotechnology, Faculty of Biological Sciences, Tehran North Branch, Islamic Azad University, Tehran, Iran
3- Department of Biochemistry and Genetics, School of Medicine, Arak University of Medical Sciences, Arak, Iran ,mtu.q220@gmail.com
2- Department of Microbial Biotechnology, Faculty of Biological Sciences, Tehran North Branch, Islamic Azad University, Tehran, Iran
3- Department of Biochemistry and Genetics, School of Medicine, Arak University of Medical Sciences, Arak, Iran ,
Abstract: (714 Views)
Introduction: Gestational diabetes is defined as hyperglycemia with onset or first diagnosis during pregnancy, with a lower frequency than general diabetes. Overweight and obesity, old age at the time of pregnancy, previous history of gestational diabetes, family history of type 2 diabetes, and race are risk factors for gestational diabetes. Recently, the relationship between two polymorphisms (rs9939609 and rs1421085) of Fat mass and obesity-associated (FTO) gene and the risk of gestational diabetes has been investigated in some studies with conflicting results. Therefore, our aim of the present study was to investigate the association study of rs1421085 and rs9939609 of the FTO gene on gestational diabetes.
Methods: In this case-control study, five cc of peripheral blood was collected from 100 cases with gestational diabetes and 116 control pregnant women from Taleghani Hospital in Arak, and then DNA was extracted. After designing the specific primers, the genotypes were determined by the Tetra ARMS-PCR method. Demographic information was compared with genotypes between the two groups were compared using SNPSTAT software.
Results: A significant correlation was observed between obesity, BMI before and during pregnancy, HbA1c, FBS, cholesterol, and triglyceride levels among mothers with gestational diabetes compared to healthy pregnant mothers P = 0.0001. According to data analysis, there was no significant association between rs1421085 and rs9939609 of the FTO gene with gestational diabetes.
Conclusions: Considering the conflicting results between the association of FTO gene polymorphisms with gestational diabetes, to better identify and understand the pathogenesis of the disease, more studies with a higher number of samples and more racial groups are needed. In the future, identifying the profile and locations of genetic susceptibility to gestational diabetes can be used in the patient's management.
Methods: In this case-control study, five cc of peripheral blood was collected from 100 cases with gestational diabetes and 116 control pregnant women from Taleghani Hospital in Arak, and then DNA was extracted. After designing the specific primers, the genotypes were determined by the Tetra ARMS-PCR method. Demographic information was compared with genotypes between the two groups were compared using SNPSTAT software.
Results: A significant correlation was observed between obesity, BMI before and during pregnancy, HbA1c, FBS, cholesterol, and triglyceride levels among mothers with gestational diabetes compared to healthy pregnant mothers P = 0.0001. According to data analysis, there was no significant association between rs1421085 and rs9939609 of the FTO gene with gestational diabetes.
Conclusions: Considering the conflicting results between the association of FTO gene polymorphisms with gestational diabetes, to better identify and understand the pathogenesis of the disease, more studies with a higher number of samples and more racial groups are needed. In the future, identifying the profile and locations of genetic susceptibility to gestational diabetes can be used in the patient's management.
Type of Study: Original Atricle |
Subject:
Basic Sciences
Received: 2024/02/26 | Accepted: 2024/05/1
Received: 2024/02/26 | Accepted: 2024/05/1
References
1. Alam U, Asghar O, Azmi S, Malik RA. General aspects of diabetes mellitus. Handb Clin Neurol. 2014:126:211-22. pmid: 25410224 doi: 10.1016/B978-0-444-53480-4.00015-1
2. Khan RMM, Chua ZJY, Tan JC, Yang Y, Liao Z, Zhao Y. From pre-diabetes to diabetes: diagnosis, treatments and translational research. Medicina (Kaunas). 2019;55(9):546. pmid: 31470636 doi: 10.3390/medicina55090546
3. McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47. pmid: 31296866 doi: 10.1038/s41572-019-0098-8
4. Kim C, Berger DK, Chamany S. Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care. 2007;30(5):1314-9.
5. Gu L, Shigemasa K, Ohama K. Increased expression of IGF II mRNA-binding protein 1mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer. Int J Oncol. 2004;24(3):671-8. pmid: 14767552
6. Tarnowski M, Bujak J, Kopytko P, Majcher S, Ustianowski P, Dziedziejko V, et al. Effect of FTO and IGF2BP2 gene polymorphisms on duration of pregnancy and Apgar scores in women with gestational diabetes. Journal of Obstetrics and Gynaecology. J Obstet Gynaecol. 2019;39(2):151-6. pmid:30371117 doi: 10.1080/01443615.2018.1502263
7. Tsai F-J, Yang C-F, Chen C-C, Chuang L-M, Lu C-H, Chang C-T, et al. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet. 2010;6(2):e1000847. pmid: 20174558 doi: 10.1371/journal.pgen.1000847
8. Kalliala I, Markozannes G, Gunter MJ, Paraskevaidis E, Gabra H, Mitra A, et al. Obesity and gynaecological and obstetric conditions: umbrella review of the literature. BMJ. 2017; 359:j4511. pmid: 29074629 DOI: 10.1136/bmj.j4511
9. Younus LA, Algenabi AHA, Abdul-Zhara MS, Hussein MK. FTO gene polymorphisms (rs993960 and rs17817449) as predictors of Type 2 Diabetes Mellitus in obese Iraqi population. Gene. 2017:627:79-84. pmid: 28603074 doi: 10.1016/j.gene.2017.06.005
10. Abdel Rahman A, Megied A, Baz R, Wafa A, Zekred E. Association of obesity with rs 1421085 and rs 9939609 polymorphisms of FTO gene with T2DM in Egyptian females. Int J Pharm Pharm Sci. 2018;10(9):73. doi: 10.22159/ijpps.2018v10i9.22747
11. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is
12. associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889-94. pmid: 17434869 doi: 10.1126/science.1141634
13. Sevgi M, Rigoux L, Kühn AB, Mauer J, Schilbach L, Hess ME,
14. et al. An obesity-predisposing variant of the FTO gene regulates D2R-dependent reward learning. J Neurosci 2015;35(36):12584-92. pmid: 26354923 doi: 10.1523/JNEUROSCI.1589-15.2015
15. Peng S, Zhu Y, Xu F, Ren X, Li X, Lai M. FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Med. 2017;9:71. pmid: 21651756 doi: 10.1186/1741-7015-9-71
16. Lin Z, Wang Y, Zhang B, Jin Z. Association of type2 diabetes susceptible genes GCKR, SLC30A8, and FTO polymorphisms with gestational diabetes mellitus risk: a meta-analysis. Endocrine. 2018;62(1):34-45. pmid: 30091126 doi: 10.1007/s12020-018-1651-z
17. He H, Cao W-t, Zeng Y-h, Huang Z-q, Du W-r, Zhao Y-z, et al. Lack of associations between the FTO polymorphisms and gestational diabetes: a meta-analysis and trial sequential analysis. Gene. 2018:677:169-75. pmid: 30055308 doi: 10.1016/j.gene.2018.07.064
18. Anghebem-Oliveira MI, Martins BR, Alberton D, Ramos EAdS, Picheth G, Rego FGdM. Type 2diabetes-associated genetic variants of FTO, LEPR, PPARg, and TCF7L2 in gestational diabetes in a Brazilian population. Arch Endocrinol Metab. 2017;61(3):238-48. pmid: 28699988 doi: 10.1590/2359-3997000000258
19. Franzago M, Fraticelli F, Nicolucci A, Celentano C, Liberati M, Stuppia L, et al. Molecular analysis of a genetic variants panel related to nutrients and metabolism: association with susceptibility to gestational diabetes and cardiometabolic risk in affected women. Journal of diabetes research.
20. J Diabetes Res. 2017; 2017: 4612623. pmid: 28133617 doi: 10.1155/2017/4612623
21. Lorenzo-Almorós A, Hang T, Peiró C, Soriano-Guillén L, Egido J, Tuñón J, et al. Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases. Cardiovasc Diabetol. 2019;18(1):140. pmid: 31666083 doi: 10.1186/s12933-019-0935-9
22. Freinkel N. Banting Lecture 1980: Of pregnancy and progeny. Diabetes. 1980;29(12):1023-35. pmid: 7002669 doi: 10.2337/diab.29.12.1023
23. Catalano PM. Obesity and pregnancy-the propagation of a viscous cycle? J Clin Endocrinol Metab.2003;88(8):3505-6. doi: 10.1210/jc.2003-031046
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
